Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 730.00p on 09-01-2026 at 19:35:07
Change -21.00p -2.8%
Buy 735.00p
Sell 733.00p
Last Trade: Buy 3,030.00 at 741.866p
Day's Volume: 263,974
Last Close: 730.00p
Open: 750.00p
ISIN: GB00BDFBVT43
Day's Range 730.00p - 750.00p
52wk Range: 232.50p - 765.00p
Market Capitalisation: £881.49m
VWAP: 739.26452p
Shares in Issue: 120.75m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 3,030 741.866p SI Trade
Negotiated Trade
16:47:02 - 09-Jan-26
Buy* 7,244 743.51691p Suspected BUY Trade
16:38:47 - 09-Jan-26
Sell* 26 730.00p Automatic Execution
16:36:14 - 09-Jan-26
Sell* 489 730.00p Automatic Execution
16:35:27 - 09-Jan-26
Sell* 34,576 730.00p Uncrossing Trade
16:35:27 - 09-Jan-26
Sell* 406 733.366p Negotiated Trade
16:29:49 - 09-Jan-26
Buy* 2 735.00p Automatic Execution
16:29:42 - 09-Jan-26
Buy* 89 735.00p Automatic Execution
16:29:42 - 09-Jan-26
Buy* 40 735.00p SI Trade
16:29:33 - 09-Jan-26
Buy* 1 735.00p Automatic Execution
16:29:33 - 09-Jan-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
9th Jan 2026 (Fri) 750.00 750.00 730.00 730.00 263,974
8th Jan 2026 (Thu) 721.00 765.00 717.00 751.00 710,116
7th Jan 2026 (Wed) 700.00 736.00 698.00 728.00 304,768
6th Jan 2026 (Tue) 680.00 697.00 669.00 697.00 299,916
5th Jan 2026 (Mon) 659.00 681.00 654.00 663.00 437,376
2nd Jan 2026 (Fri) 620.00 658.00 620.00 655.00 272,501
1st Jan 2026 (Thu) 617.00 617.00 617.00 617.00 0
31st Dec 2025 (Wed) 593.00 619.00 593.00 617.00 36,901
30th Dec 2025 (Tue) 622.00 632.00 616.00 620.00 143,377
29th Dec 2025 (Mon) 598.00 622.00 598.00 617.00 86,496
26th Dec 2025 (Fri) 604.00 604.00 604.00 604.00 0
25th Dec 2025 (Thu) 604.00 604.00 604.00 604.00 0
24th Dec 2025 (Wed) 590.00 612.00 590.00 604.00 21,434
23rd Dec 2025 (Tue) 595.00 624.00 582.00 610.00 193,057
22nd Dec 2025 (Mon) 573.00 586.00 570.00 585.00 177,194
19th Dec 2025 (Fri) 570.00 596.00 570.00 576.00 776,963
18th Dec 2025 (Thu) 613.00 617.00 571.00 584.00 230,781
17th Dec 2025 (Wed) 600.00 613.00 584.00 587.00 239,274
16th Dec 2025 (Tue) 587.00 612.00 587.00 602.00 251,992
15th Dec 2025 (Mon) 630.00 630.00 587.00 603.00 897,509
12th Dec 2025 (Fri) 635.00 649.00 626.00 626.00 101,846
11th Dec 2025 (Thu) 635.00 646.00 630.00 641.00 151,156
10th Dec 2025 (Wed) 630.00 648.00 630.00 641.00 432,992
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
2nd Jan 2026 7:00 am RNS Block Listing Return
2nd Jan 2026 7:00 am RNS Block Listing Return
2nd Jan 2026 7:00 am RNS Total Voting Rights
2nd Jan 2026 7:00 am RNS Total Voting Rights
8th Dec 2025 3:15 pm RNS PDMR Dealing
1st Dec 2025 7:00 am RNS Total Voting Rights
3rd Nov 2025 4:55 pm RNS Holding(s) in Company
3rd Nov 2025 7:00 am RNS Total Voting Rights
29th Oct 2025 1:59 pm RNS-R OXB honoured at 2025 CDMO Leadership Awards Europe
27th Oct 2025 7:00 am RNS-R OXB to participate in investor conferences
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

LONDON BROKER RATINGS: Berenberg raises M&S; BofA cuts Barratt Redrow

9th Jan 2026 10:04

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: RBC raises Diageo; BofA cuts JD Sports Fashion

6th Jan 2026 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: JPMorgan cuts M&G, UBS cuts Trainline

8th Dec 2025 09:39

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and on Friday: Read More

Oxford BioMedica expands US footprint as buys North Carolina facility

7th Oct 2025 09:22

(Alliance News) - Oxford BioMedica PLC on Tuesday said it has closed a deal to acquire a cell and gene therapy viral vector manufacturing facility in Durham, North Carolina. Read More

Oxford BioMedica narrows interim loss, backs annual outlook

23rd Sep 2025 10:48

(Alliance News) - Oxford BioMedica PLC on Tuesday hailed its "strong revenue pipeline" and growth visibility, as it kept its financial outlook for the full-year unaltered. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,124.60
Change79.91

Login to your account

Forgot Password?

Not Registered